Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

Daiana Stolz(University of Freiburg), Takudzwa Mkorombindo(University of Alabama at Birmingham), Desirée Schumann(University Hospital of Basel), Àlvar Agustí(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Samuel Y. Ash(Brigham and Women's Hospital), Mona Bafadhel(University of Oxford), Chunxue Bai(Fudan University), James D. Chalmers(University of Dundee), Gerard J. Criner(Temple University), Shyamali C Dharmage(The University of Melbourne), Frits M.E. Franssen(Ciro), Urs Frey(University Children’s Hospital Basel), MeiLan K. Han(University of Michigan), Nadia N. Hansel(Johns Hopkins University), Nathaniel M. Hawkins(University of British Columbia), Ravi Kalhan(Northwestern University), Mélanie Königshoff(University of Pittsburgh), Fanny W.S. Ko(Chinese University of Hong Kong), Trisha M. Parekh(University of Alabama at Birmingham), Pippa Powell(British Lung Foundation), Maureen Rutten‐van Mölken(Erasmus University Rotterdam), Jodie L. Simpson(University of Newcastle Australia), Don D. Sin(St. Paul's Hospital), Yuanlin Song(Fudan University), Bélâ Suki(Boston University), Thierry Troosters(KU Leuven), George R. Washko(Harvard University), Tobias Welte(Medizinische Hochschule Hannover), Mark T. Dransfield(University of Alabama at Birmingham)
The Lancet
September 1, 2022
Cited by 638Open Access
Full Text

Abstract

the development of curative and regenerative therapies that go beyond the largely symptomatic treatment options available; and (6) deployment of public health preventive strategies for banning smoking and maintaining clean air. We are fully cognisant that the scientific evidence to support some of our proposals is lacking. However, it is the intention of the Commission to generate discourse and debate, catalyse momentum, and provide a much-needed new vision to set the course towards the elimination of COPD.


Related Papers